NCT07267052 Acute Effects of Transcutaneous Electrical Nerve Stimulation at Acupoints on Nociceptive Transmission
| NCT ID | NCT07267052 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China Medical University Hospital |
| Condition | Pain Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 35 participants |
| Start Date | 2025-09-05 |
| Primary Completion | 2026-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 35 participants in total. It began in 2025-09-05 with a primary completion date of 2026-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if transcutaneous electrical nerve stimulation (TENS) applied to acupoints can modulate pain transmission and cortical processing in healthy adult volunteers. The main questions it aims to answer are: * Does TENS at Zhongzhu (SJ3) and Hegu (LI4) change pain-related evoked potentials (PREPs)? * Does acupoint electrical stimulation alter nociceptive pathways reflected by PREP waveform modulation? Researchers will compare PREPs recorded before and after TENS at the two acupoints to see if TENS produces measurable effects on cortical nociceptive responses. Participants will receive low-frequency TENS applied to Zhongzhu (SJ3) and Hegu (LI4), and undergo PREP assessments before and after the intervention to measure cortical responses to standardized noxious stimuli.
Eligibility Criteria
Inclusion Criteria: * Healthy Adult * 20 years or older * The absence of chronic medical conditions * No history of drug allergies * No skin disorders * No current use of medications that could affect study outcomes * Participants maintain a regular daily routine * No history of substance or medication abuse Exclusion Criteria: * History of malignant tumors * History of hand disorders * Has implanted cardiac pacemakers * Pregnancy * Epilepsy * Any other condition that may interfere with the study procedures
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07267052 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Pain Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07267052 currently recruiting?
Yes, NCT07267052 is actively recruiting participants. Contact the research team at sherrie@mail.cmu.edu.tw for enrollment information.
Where is the NCT07267052 trial being conducted?
This trial is being conducted at Taichung, Taiwan.
Who is sponsoring the NCT07267052 clinical trial?
NCT07267052 is sponsored by China Medical University Hospital. The trial plans to enroll 35 participants.